Search results for CONTACT COLASHIP.SHOP TO

Results found

Displaying items 1051 - 1060 of 1535 in total

• Export opportunity Drugs

  Conclusion of non-exclusive discount contracts in accordance with §§ 130a Para. 8/130c Para. 1 SGB V for drugs with the active ingredient apremilast (L04AA32) …

• Export opportunity Drugs

  Conclusion of non-exclusive discount contracts in accordance with §§ 130a Para. 8/130c Para. 1 SGB V for drugs with the active ingredient teriflunomide (L04AA3…

• Export opportunity Job placement

  This framework agreement applies to the conclusion and execution of temporary employment contracts between the hirer and the lender in one or more of the follo…

• Export opportunity 61--power supply

  CONTACT INFORMATION|4|N791.13|LPD|215.697.3528|Destiny.n.wiatr.civ@us.nav.mil| COMMERCIAL ITEM PROCUREMENT NOTICE - AWARD|4||||| ITEM UNIQUE IDENTIFICATION AND…

• Export opportunity Drugs

  The subject of this publication is the conclusion of non-exclusive rebate contracts pursuant to Section 130a (8) SGB V for drugs with the active ingredient inf…

• Export opportunity 59--antenna assembly

  View Changes CONTACT INFORMATION|4|N763.10|P5M|215-697-9035|CARMELENA.OLDROYD@NAVY.MIL| ITEM UNIQUE IDENTIFICATION AND VALUATION (JAN 2023)|19|||||||||||||||||…

• Export opportunity Drugs

  Conclusion of a non-exclusive discount agreement pursuant to Section 130a (8) of the German Social Code, Book V (SGB V) for drugs containing the active ingredi…

• Export opportunity Immunosuppressants

  Conclusion of a non-exclusive discount agreement pursuant to Section 130a (8) of the German Social Code, Book V, for drugs containing the active ingredient fin…

• Export opportunity Ophthalmics

  Conclusion of a non-exclusive discount agreement pursuant to Section 130a (8) SGB V on drugs with the active ingredient bimatoprost (ATC code: S01EE03) within …

• Export opportunity Medicines for the digestive tract and metabolism

  Conclusion of a non-exclusive discount agreement in accordance with Section 130a (8) SGB V for medicinal products with the active ingredient multienzyme (lipas…